abstract |
The invention relates to pharmaceutical preparations, which are suitable for the oral application of liposomically encapsulated paclitaxel, its derivatives and taxane. Said preparations preferably contain at least one immunomodulator, preferably cyclosporine, and/or at least one cytokine, preferably PEG-cytokine. |